South Korea Allergy Diagnostics Market (2026-2031)
The South Korea Allergy Diagnostics Market was valued at $69.6 Million in 2026 and projected to reach to $117.5 Million by 2031, representing a compound annual growth rate of 11.0%. South Korea's allergy diagnostics market is positioned for sustained expansion through 2031, driven by heightened consumer awareness of allergic diseases and the critical importance of early diagnosis.
South Korea Allergy Diagnostics Market Trends and Insights
- This 11.0% compound annual growth rate reflects South Korea's advanced healthcare infrastructure, rising prevalence of allergic diseases, and increasing consumer awareness of diagnostic testing.
- South Korea's aging population and urbanization trends are driving demand for accurate, rapid allergy identification methods across clinical and home-based settings. The South Korea allergy diagnostics sector benefits from strong government healthcare investments and a highly educated patient population seeking preventive care solutions.
- South Korea's pharmaceutical and diagnostic companies are innovating in immunoassay and molecular testing platforms to capture growing market share.
- Between 2026 and 2031, South Korea is expected to see accelerated adoption of point-of-care testing and digital health integration, positioning the country as a regional leader in allergy diagnostic innovation within the Asia Pacific region..
Key Market Statistics
- CAGR (2026-2031) 11.0% CAGR
- Market Size, 2026 ~USD 69.6 Million
- Forecast, 2031 ~USD 117.5 Million
- Country South Korea
South Korea Allergy Diagnostics Market Overview
Market Valuation Growth :
South Korea's allergy diagnostics market is valued at USD 69.6 million in 2026, with projections reaching USD 117.5 million by 2031, representing a strong 11% CAGR that outpaces the global average of 9.6%.
Advanced Healthcare Infrastructure :
South Korea's sophisticated medical technology ecosystem and high healthcare spending per capita enable rapid adoption of innovative allergy diagnostic solutions and cutting-edge testing methodologies.
Rising Allergic Disease Prevalence :
Increasing rates of allergic conditions driven by urbanization, environmental factors, and lifestyle changes are creating sustained demand for accurate diagnostic testing across South Korea's population.
Aging Population Demographics :
South Korea's rapidly aging demographic profile increases the prevalence of age-related allergic conditions, driving higher diagnostic testing volumes and creating long-term market expansion opportunities.
South Korea Allergy Diagnostics Market Dynamics
- The country's advanced healthcare infrastructure, combined with strong government support for diagnostic innovation, creates a favorable environment for market players.
- Increasing healthcare accessibility and rising disposable incomes among South Korean consumers are expected to drive higher testing adoption rates across both urban and emerging markets. The market will benefit from technological advancements in molecular and immunological testing platforms, as well as growing integration of digital health solutions in diagnostic workflows.
- South Korea's emphasis on precision medicine and preventive healthcare aligns with global trends in allergy diagnostics, positioning the nation as a key growth market in the Asia-Pacific region through 2031..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- South Korea's allergy diagnostics market is valued at USD 69.6 million in 2026 and will reach USD 117.5 million by 2031, representing an 11.0% CAGR.
- South Korea's advanced healthcare system and high diagnostic awareness drive faster market growth compared to global averages.
- South Korea is witnessing increased adoption of point-of-care and digital-integrated allergy testing solutions among healthcare providers.
- South Korea's aging population and rising allergic disease prevalence create sustained demand for innovative diagnostic technologies through 2031.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
South Korea Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Device Manufacturers : In vitro diagnostics and allergy testing equipment manufacturers need South Korea-specific market data to assess expansion opportunities, competitive positioning, and regulatory requirements in this advanced healthcare market.
- Healthcare Investment Firms : Private equity and venture capital investors targeting South Korea's healthcare sector require detailed market sizing and growth forecasts to evaluate investment returns and portfolio opportunities in allergy diagnostics.
- Clinical Laboratory Operators : Laboratory networks and diagnostic service providers need South Korea market intelligence to plan capacity expansion, service offerings, and technology investments aligned with growing diagnostic demand.
- Pharmaceutical & Biotech Companies : Companies developing allergy treatments and therapeutics require market data on diagnostic prevalence and testing patterns in South Korea to inform clinical trial design and commercialization strategies.
- Healthcare Consultants & Analysts : Management consulting firms and market research professionals need comprehensive South Korea allergy diagnostics data to support client strategy development, market entry planning, and competitive analysis.
Key Companies in the South Korea Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- Market-Specific Growth Projections : Gain precise forecasting data for South Korea's allergy diagnostics market with detailed CAGR analysis (11%) and revenue projections through 2031, enabling accurate business planning and investment decisions.
- Competitive Landscape Intelligence : Understand South Korea's unique competitive dynamics, local market players, and barriers to entry specific to the Korean healthcare system and regulatory environment.
- Demographic & Epidemiological Insights : Access detailed analysis of South Korea's aging population trends, urbanization patterns, and rising allergic disease prevalence driving diagnostic demand in this high-income market.
- Healthcare Infrastructure Assessment : Evaluate South Korea's advanced medical technology adoption rates, healthcare spending patterns, and reimbursement mechanisms to identify market entry and expansion opportunities.
- Strategic Market Positioning : Leverage South Korea-specific market data to benchmark performance against regional competitors and identify untapped segments within this high-growth Asia-Pacific market.
Frequently asked questions
What is the current size of South Korea's allergy diagnostics market?
South Korea's allergy diagnostics market is valued at USD 69.6 million in 2026 and is projected to grow to USD 117.5 million by 2031.
What is the growth rate of South Korea's allergy diagnostics market?
South Korea's allergy diagnostics market is growing at a compound annual growth rate (CAGR) of 11.0% from 2026 to 2031.
What factors are driving growth in South Korea's allergy diagnostics market?
South Korea's market growth is driven by advanced healthcare infrastructure, rising allergic disease prevalence, increasing diagnostic awareness, an aging population, and urbanization trends.
Which diagnostic technologies are gaining traction in South Korea?
South Korea is seeing increased adoption of point-of-care testing, immunoassay platforms, molecular testing methods, and digital health-integrated diagnostic solutions.
How does South Korea's allergy diagnostics market compare to global trends?
South Korea's 11.0% CAGR outpaces the global average of 9.6%, reflecting the country's advanced healthcare system and high patient engagement in diagnostic testing.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report